Breaking News

Coldstream Names FormDev Director

By Gil Roth | November 18, 2013

Raiche to lead process, product development teams

Adrian Raiche, Ph.D. has been named director of Formulation Development at Coldstream Laboratories, Inc. In this position, Dr. Raiche will head the formulation development group at Coldstream and will oversee teams focusing on process and product development, lyophilization and scale-up activities for manufacturing in the company's sterile manufacturing facility.

Dr. Raiche brings to Coldstream expertise in numerous aspects of pharma development, particularly lyophilization and potent compound handling. Most recently, he served as manager of Pharmaceutical Development at Summit Biosciences contributing to formulation, analytical and process development of nasal spray products. Prior experience includes tenures at SiO2 Medical Products, Brookwood Pharmaceuticals and Bausch and Lomb.

"We are pleased with Dr. Raiche's addition to the Coldstream team," said Coldstream's president and chief executive officer, Eric Smart. "His knowledge of process and product development enhances Coldstream's focus on the development of parenterals, especially our emphasis on highly active compounds."

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important